• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶 1 间接参与丝裂原活化蛋白激酶 p38 的表观遗传调控,从而推动肺癌的进展。

HDAC1 is indirectly involved in the epigenetic regulation of p38 MAPK that drive the lung cancer progression.

机构信息

Department of Integrated Chinese and Western Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5980-5986. doi: 10.26355/eurrev_201809_15932.

DOI:10.26355/eurrev_201809_15932
PMID:30280780
Abstract

OBJECTIVE

p38 MAPK are a class of protein kinase that may induce or prevent apoptosis in different circumstance. Emerging researches show that it plays a vital role in tumor progression and therefore understanding its dual role in different stages of lung cancer are important to investigate. Also in this study, we planned to understand its upstream target proteins like HDAC1 and uPAR which are responsible for p38 MAPK activation in the pathway.

MATERIALS AND METHODS

We initially develop lung cancer mice model by exposing them to high nicotine content tobacco smoke. The pathological stages of initial and advanced lung cancer are observed and confirmed through histological sectioning. The expression of HDAC1, uPAR and p38 MAPK are observed and analyzed in different stages of lung cancer using immunohistochemistry and Western blotting.

RESULTS

After 4 and 6 months of regular exposure of high nicotine content smoke, the A/J strain mice develop initial and advanced stage of lung cancer. The initial stage cancer develops thick tissue layers with fibrosis whereas advanced stages of lung cancer show more proliferative cells. The expression of HDAC1 and uPAR shows the minimal expression pattern in control and initial stages of lung cancer, but its expression increased in advanced stage of cancer. In case of phospho-p38 MAPK, mild expression was observed almost in every individual cell in the initial stages of cancer, which implies its protective role in preventing advanced stage of cancer. But in advanced stage of lung cancer, we observed dysregulated overexpression of phospho-p38 MAPK.

CONCLUSIONS

The epigenetic regulation of uPAR by HDAC1 confirms its indirect role in regulating p38 MAPK as tumor progress.

摘要

目的

p38 MAPK 是一类蛋白激酶,在不同的环境下可能诱导或阻止细胞凋亡。新的研究表明,它在肿瘤进展中起着至关重要的作用,因此了解其在肺癌不同阶段的双重作用对于研究它是很重要的。此外,在这项研究中,我们计划了解其上游靶蛋白,如负责 p38 MAPK 通路激活的 HDAC1 和 uPAR。

材料与方法

我们首先通过使 A/J 品系小鼠暴露于高尼古丁含量的烟雾中来建立肺癌小鼠模型。通过组织切片观察和确认肺癌的初始和晚期阶段的病理变化。使用免疫组织化学和 Western blot 分析在不同阶段的肺癌中观察和分析 HDAC1、uPAR 和 p38 MAPK 的表达。

结果

经过 4 个月和 6 个月的定期高尼古丁含量烟雾暴露,A/J 品系小鼠发展出肺癌的初始和晚期阶段。早期肺癌发展出厚的组织层和纤维化,而晚期肺癌则显示出更多的增殖细胞。HDAC1 和 uPAR 的表达在对照和肺癌的初始阶段表现出最小的表达模式,但在癌症的晚期阶段表达增加。对于磷酸化 p38 MAPK,在癌症的初始阶段,几乎每个细胞都观察到轻度表达,这表明它在防止癌症晚期方面具有保护作用。但是在肺癌的晚期阶段,我们观察到磷酸化 p38 MAPK 的失调过表达。

结论

HDAC1 对 uPAR 的表观遗传调控证实了其在调节 p38 MAPK 作为肿瘤进展中的间接作用。

相似文献

1
HDAC1 is indirectly involved in the epigenetic regulation of p38 MAPK that drive the lung cancer progression.组蛋白去乙酰化酶 1 间接参与丝裂原活化蛋白激酶 p38 的表观遗传调控,从而推动肺癌的进展。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5980-5986. doi: 10.26355/eurrev_201809_15932.
2
Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.尼古丁通过丝裂原活化蛋白激酶和活性氧信号通路刺激 ECV304 内皮细胞中尿激酶型纤溶酶原激活物受体的表达和细胞侵袭性。
Toxicol Appl Pharmacol. 2012 Mar 1;259(2):248-56. doi: 10.1016/j.taap.2012.01.002. Epub 2012 Jan 9.
3
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.尿激酶型纤溶酶原激活物受体的抑制通过ERK/p38信号通路的调节抑制胰腺腺癌细胞的增殖和迁移。
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8. doi: 10.1016/j.biocel.2009.03.004. Epub 2009 Mar 21.
4
Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.去乙酰化 GM3 促进 uPAR 相关膜分子复合物激活转移性黑色素瘤中的 p38 MAPK。
Mol Cancer Res. 2013 Jun;11(6):665-75. doi: 10.1158/1541-7786.MCR-12-0270-T. Epub 2013 Mar 22.
5
SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway .SNAI2 通过调节 u-PAR 表达和 ERK/p38 信号通路活性增强 HPV-阴性宫颈癌细胞休眠。
Oncol Rep. 2024 Aug;52(2). doi: 10.3892/or.2024.8763. Epub 2024 Jun 28.
6
Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.半乳糖凝集素-1 通过上调 p38 MAPK、ERK 和环氧化酶-2 促进肺癌的进展和化疗耐药性。
Clin Cancer Res. 2012 Aug 1;18(15):4037-47. doi: 10.1158/1078-0432.CCR-11-3348. Epub 2012 Jun 13.
7
Role of mitogen-activated protein kinase pathways in migration of gingival epithelial cells in response to stimulation by cigarette smoke condensate and infection by Porphyromonas gingivalis.丝裂原活化蛋白激酶通路在牙龈上皮细胞响应香烟烟雾冷凝物刺激和牙龈卟啉单胞菌感染后的迁移中的作用。
J Periodontal Res. 2016 Oct;51(5):613-21. doi: 10.1111/jre.12341. Epub 2015 Dec 15.
8
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).细胞外信号调节激酶(丝裂原活化蛋白激酶)活性作为肿瘤生长和休眠的决定因素;由p38(应激激活蛋白激酶)调节
Cancer Res. 2003 Apr 1;63(7):1684-95.
9
Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.Krüppel样因子17通过Src/p38/丝裂原活化蛋白激酶信号通路抑制尿激酶型纤溶酶原激活剂基因表达,从而抑制人肺腺癌细胞的侵袭。
Oncotarget. 2017 Jun 13;8(24):38743-38754. doi: 10.18632/oncotarget.17020.
10
Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.二甲双胍抑制 p38 MAPK 依赖性错配修复蛋白同源物-2(MSH2)的表达,增强吉非替尼对人鳞状肺癌细胞的细胞毒性。
Lung Cancer. 2013 Dec;82(3):397-406. doi: 10.1016/j.lungcan.2013.09.011. Epub 2013 Sep 25.

引用本文的文献

1
Expression patterns and therapeutic implications of histone deacetylase-1 across carcinomas: a comprehensive molecular docking and MD simulation study.组蛋白去乙酰化酶-1 在各类癌中的表达模式及治疗意义:一项全面的分子对接和 MD 模拟研究。
Med Oncol. 2022 Sep 29;39(12):209. doi: 10.1007/s12032-022-01811-y.
2
The Potential Mechanism of HDAC1-Catalyzed Histone Crotonylation of Caspase-1 in Nonsmall Cell Lung Cancer.HDAC1催化的半胱天冬酶-1组蛋白巴豆酰化在非小细胞肺癌中的潜在机制
Evid Based Complement Alternat Med. 2022 Aug 2;2022:5049116. doi: 10.1155/2022/5049116. eCollection 2022.
3
Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients.
全面分析组蛋白去乙酰化酶基因在胶质瘤患者预后和免疫浸润中的作用。
Aging (Albany NY). 2022 May 11;14(9):4050-4068. doi: 10.18632/aging.204071.
4
ZCCHC14 regulates proliferation and invasion of non-small cell lung cancer through the MAPK-P38 signalling pathway.ZCCHC14 通过 MAPK-P38 信号通路调节非小细胞肺癌的增殖和侵袭。
J Cell Mol Med. 2021 Feb;25(3):1406-1414. doi: 10.1111/jcmm.16223. Epub 2020 Dec 20.
5
The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma.组蛋白乙酰化/甲基化介导的凋亡基因调控在肝细胞癌中的作用。
Int J Mol Sci. 2020 Nov 24;21(23):8894. doi: 10.3390/ijms21238894.
6
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.靶向癌症治疗的表观遗传调节剂:机制和临床试验进展。
Signal Transduct Target Ther. 2019 Dec 17;4:62. doi: 10.1038/s41392-019-0095-0. eCollection 2019.
7
Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations.中药延长表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)治疗携带 EGFR 突变的非小细胞肺癌(NSCLC)患者无进展生存期并增强治疗效果。
Med Sci Monit. 2019 Nov 9;25:8430-8437. doi: 10.12659/MSM.917251.